In agreement with our results, treatment with tPA has been shown to lead to improved chemotherapeutic activity of nanoparticles4; however, the use of tPA should be restricted, especially in patients with pathologies associated with intracranial hemorrhage diseases37,38. Here, PLAT is linked to intracranial hemorrhage.